🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to make Iodine-131 Anti-B1 Antibody ...
Status
Unknown
Location
Central Recruiting Information
Start Date
1998-09
Trial ID
NCT00022958
Treatments Being Tested
The majority of head and neck cancer patients do not respond to immunothera...
Status
Active Not Recruiting
Location
UC San Diego Moores Cancer Center
Start Date
2024-02-23
Trial ID
NCT05787639
Treatments Being Tested
The purpose of this study is to determine the complete response rate when C...
Status
Completed
Location
UPMC Cancer Centers
Start Date
2003-11
Trial ID
NCT00177554
Treatments Being Tested
This phase III trial studies rituximab and yttrium Y-90 ibritumomab tiuxeta...
Status
Terminated
Location
Mayo Clinic in Rochester
Start Date
2015-02-11
Trial ID
NCT02320292
Treatments Being Tested
RATIONALE: Radiolabeled monoclonal antibodies can locate tumor cells and de...
Status
Completed
Location
University of Alabama at Birmingham Comprehensive Cancer Center
Start Date
1999-11
Trial ID
NCT00005592
Treatments Being Tested
The purpose of this study is to evaluate the safety and clinical activity o...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2018-02-02
Trial ID
NCT03161379
Treatments Being Tested
RATIONALE: Monoclonal antibodies such as rituximab and yttrium Y 90 ibritum...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2003-02-10
Trial ID
NCT00058422
This study is being done to select an appropriate TF2 bsMAb dose suitable f...
Status
Withdrawn
Location
Georgetown University Medical Center
Start Date
2011-02
Trial ID
NCT01273402
Treatments Being Tested
RATIONALE: Radiolabeled monoclonal antibodies can locate cancer cells and d...
Status
Completed
Location
Garden State Cancer Center
Start Date
1998-04
Trial ID
NCT00004084
Treatments Being Tested
The purpose of this trial is to determine the safety of 90Y-hMN14 at differ...
Status
Completed
Location
Hoag Cancer Center
Start Date
2000-01
Trial ID
NCT00040599
Treatments Being Tested